關鍵數據
8.440今開
9.030最高
6.79K成交量
虧損本益比TTM
虧損本益比動
--股利TTM
0.03%換手率
8.780昨收
8.370最低
58.01K成交額
虧損本益比靜
3.52市淨率
0.00%股息率 TTM
-43.14%ROA
10.14052週最高
25.49量比
-14.64M淨利潤
21.77M總股本
-1.3591每股盈餘TTM
2.37Beta
-51.74%ROE
4.50052週最低
7.52%振幅
93.58%毛利率
186.57M總市值
1.48回報/風險
4.15%風險率

即將為您帶來更多新聞,敬請期待。 。 。
Alpha Cognition Inc評分
-0.02與上次評分對比預測8.00
財務診斷9.15
技術分析3.86
公司估值7.25
機構認同度5.00
風險評估3.78
分析師評級
買入評級
18.997目標均價
+116.36%漲幅空間
Alpha Cognition Inc 最新財報電話會記錄
Alpha Cognition (ACOG) 2026年第二季財報電話會議:ZUNVEYL 銷售額成長 71%
Alpha Cognition 的 2026 年第二季財報電話會議指出,ZUNVEYL 銷售額達 600 萬美元、季增 71%,市場採用度強勁,並調降了費用指引。
財務指標
貨幣: USD

由於公司未披露,未能獲取相關數據
貨幣: USD

由於公司未披露,未能獲取相關數據
Alpha Cognition Inc 簡介
Alpha Cognition Inc. is a commercial stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI). The Company's ZUNVEYL (benzgalantamine) product is a delayed release oral tablet formulation indicated for the treatment of mild to moderate dementia of the Alzheimer’s type in adults. Its pre-clinical development programs include ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer’s disease; ALPHA-1062 sublingual formulation; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mTBI; ALPHA-0602; ALPHA-0702 & ALPHA-0802 (Progranulin and Progranulin GEM’s) for the treatment of neurodegenerative diseases including amyotrophic lateral sclerosis or Lou Gehrig’s disease and spinal muscular atrophy, and ALPHA-1062 for the treatment of acute pancreatitis.
行業藥品
公司代碼ACOG
員工數量52
國家Canada
持股情況
| 持股股東 | 佔比 |
|---|
| Opaleye Management Inc. | 11.28% |
|---|
| Solas Capital Management, LLC | 9.04% |
|---|
| AWM Investment Company, Inc. | 7.68% |
|---|
| Manchester Management Company, L.L.C. | 5.18% |
|---|
| 股東類型 | 佔比 |
|---|
| Hedge Fund | 37.00% |
|---|
| Investment Advisor/Hedge Fund | 14.37% |
|---|
| Individual Investor | 11.45% |
|---|
| Investment Advisor | 1.24% |
|---|
常見問題
Alpha Cognition Inc(ACOG)的當前股價是多少?
Alpha Cognition Inc(ACOG)的當前股價是 8.78。
Alpha Cognition Inc 的股票代碼是什麼?
Alpha Cognition Inc的股票代碼是ACOG。
Alpha Cognition Inc股票的52週最高點是多少?
Alpha Cognition Inc股票的52週最高點是10.14。
Alpha Cognition Inc股票的52週最低點是多少?
Alpha Cognition Inc股票的52週最低點是4.50。
Alpha Cognition Inc的市值是多少?
Alpha Cognition Inc的市值是191.14M。
現在Alpha Cognition Inc(ACOG)的股票是買入、持有還是賣出?
根據分析師評級,Alpha Cognition Inc(ACOG)的總體評級為買入,目標價格為19.00。
Alpha Cognition Inc(ACOG)股票的每股收益(EPS TTM)是多少
Alpha Cognition Inc(ACOG)股票的每股收益(EPS TTM)是-1.36。